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Abstract
Background: Normal  heart  ventricular  arrhythmia  occurring  during  pregnancy  has  been 
previously  described.  Whilst  there  are  established  reports  of  catheter  ablation  to  treat 
supraventricular  arrhythmia  during  pregnancy,  there  are  no  reports  of  ablation  to  treat 
ventricular  tachycardia.                                          
Case: We  present  the  case  of  a  36  year  old  women,  31  weeks  into  an  otherwise 
uncomplicated  pregnancy,  experiencing  significant,  troublesome  and  drug  refractory 
tachycardia emanating from the right ventricular outflow tract.                                     
Conclusion: We describe  a  successful  radio  frequency  ablation  in  the  third  trimester  of 
pregnancy.
 
Case  Report                                                        
A 36-year old woman was admitted acutely to our institution with a four week history of 
increasingly intrusive palpitations associated with pre-syncope. She was 31 weeks into her 
second pregnancy having experienced no problems during the first or second trimester or at 
all during her previous pregnancy 6 years earlier. Ambulatory monitoring organised prior to 
her admission had demonstrated frequent unifocal premature ventricular contractions (PVC) 
including  couplets  and  triplets,  and short  salvos  of  non-sustained  ventricular  tachycardia 
(VT)  corresponding  with  symptoms.  The  initial  physical  examination,  electrolytes  and 
laboratory investigations were unremarkable. Obstetric assessment revealed a healthy fetus 
consistent  with  31  weeks  of  gestation.                                       
Her  electrocardiogram  during  a  typical  episode  revealed  a  monomorphic  wide-complex 
tachycardia of left bundle branch block morphology consistent with an origin from the right 
ventricular outflow tract  (Figure 1).  Echocardiography demonstrated a mildly dilated left 
ventricle with normal function and an ejection fraction of 63%. Initial attempts to control her 
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arrhythmia medically with oral and intravenous metoprolol were unsuccessful. The patient 
was subsequently treated with oral  verapamil  therapy but,  despite initial  benefit,  suffered 
with recurrent and increasingly sustained episodes of VT associated with hypotension and 
pre-syncope. Following obstetric consultation, the option of catheter ablation was offered as 
a therapeutic option. After discussion of the potential risks to the mother and foetus, both of 
the procedure and of potential radiation exposure, informed consent was obtained.           
The patient was brought to the electrophysiology laboratory in the postabsorptive state and 
placed in the left  lateral  position using a wedge to decompress the inferior vena cava.  A 
midwife was present to monitor the foetal  heart  rate.  Lead shielding of the abdomen and 
pelvis was used to shield the fetus as much as possible if any fluoroscopic radiation was 
needed. Venous access was obtained from the right femoral vein. Although we intended to  
perform the procedure with zero fluoroscopy, owing to the distortion of the pelvic anatomy 
by the gravid uterus and the tilt from the wedge, minimal fluoroscopy (60 seconds, 9.9mGy) 
was  utilised  to  position  the  catheters  in  the  heart.  Catheters  were  placed  in  the  right 
ventricular  apex and coronary sinus.                                                  
The remainder of the procedure was performed with zero-fluoroscopy using a 3-dimensional 
mapping system to create a geometrical shell of the right ventricular outflow tract (NavX, St. 
Jude Medical,  St Paul, Minneapolis,  USA). During frequent periods of non-sustained VT 
earliest  endocardial  activation was localised to the high outflow tract (Figure 2).  At this 
location  the  local  electrogram  on  the  ablation  catheter  preceded  the  onset  of  the  QRS 
complex by 33ms (Figure 2). Catheter tip pressure at this site induced sustained VT with 
subsequent radiofrequency ablation terminating VT. There was no recurrence during a 30-
minute period of observation. The procedure was uncomplicated and no further PVCs or VT 
were observed on telemetry over the following 48-hours.                                 
The  patient  remained  asymptomatic  and  interim  ambulatory  monitoring  after  8  weeks 
demonstrated no evidence of recurrent arrhythmia. She delivered a healthy child at term by 
elective  caesarean  section  without  complication.                                   
 
 
Figure 1:  12 lead ECG (25mm/second sweep) during an episode of typical  symptoms. Bursts of 
broad complex  tachycardia  are  seen  with a  left  bundle  branch block morphology and precordial  
transition at  V4 consistent  with origin form the right  ventricular  outflow tract.  Dissociated atrial  
activity (p waves) can be seen (arrow). The 6th complex along from the left is a normal sinus beat.  
Such bursts of tachycardia are characteristic of normal heart RVOT VT. 
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Figure  2:  A 3-dimensional  geometry  of  the  RV outflow tract  using  the  NavX system (St  Jude 
Medical). The left hand image shows an isochronal map of local electrical activation time in relation  
to the surface QRS (red to white is the earliest local activation suggestive of the endocardial breakout  
of the arrhythmia). The next image shows the area of ablation as represented on the NavX system (red  
dots). The right hand panel shows the local electrical signal on the ablation catheter at the point where  
subsequent  ablation  abolished  tachycardia  (top  to  bottom  surface  ECG  leads,  ablation  catheter  
proximal to distal electrode pairs. Sweep speed 100mm/second).                                       
Comment
We report a case of new onset right ventricular outflow tract tachycardia during the third 
trimester  of  pregnancy  in  an  otherwise  healthy  young  female.  Catheter  ablation  was 
successfully performed after failure of conservative treatment with antiarrhythmic drugs.     
Pregnancy is associated with an increased risk of arrhythmia in women with both structurally 
normal  and abnormal  hearts.  Furthermore,  in  women with a  prior  history of  arrhythmia, 
exacerbations  during  pregnancy  are  frequent  and  have  a  negative  impact  on  fetal  and 
neonatal outcome mostly due to a higher incidence of premature labour.[1] It is unknown 
whether this relates to the arrhythmia itself or due to concomitant use of antiarrhythmic drugs 
or  anticoagulants.                                    
Factors  predisposing to the development  or exacerbation of arrhythmia  during pregnancy 
include  significant  hemodynamic  changes,  hormonal  flux,  changes  in  autonomic  tone, 
increased sensitivity to circulating catecholamines, hypokalaemia of pregnancy, and presence 
of  structural  heart  disease.[2]                                      
There are few reports of new-onset VT during pregnancy in the absence of structural heart 
disease.[2] A previous report of 11 pregnant women with new-onset VT suggested an equal 
distribution over the three trimesters with over 70% of arrhythmias originating from the right 
ventricular  outflow tract.[2]  The mechanism of  VT initiation  in  pregnancy has  not  been 
determined but is unlikely to be simply related to circulating oestrogen concentrations since 
arrhythmia precipitation has been shown to be associated with both low oestrogen states, 
such  as  the  menopause  or  pre-menstrually,  as  well  as  high  oestrogen  states  such  as 
pregnancy.  Furthermore,  oestrogen  has  been  shown  to  demonstrate  calcium  antagonistic 
properties in cardiac myocytes which might suggest an antiarrhythmic effect. Consideration 
should also be given to the potential arrythmogenic milieu created by an imbalance between 
dominant  progesterone  and oestrogen.  There  have  been reports  of  pregnancy related  VT 
being successfully induced in the post partum period only following the administration of 
progesterone supplements.[3] On the other hand, an increase in central sympathetic activity 
has  been  reported  in  normal  pregnancy  and  an  increased  sensitivity  to  circulating 
catecholamines  during  pregnancy  has  been  proposed  as  a  potential  trigger  for  VT.[2]
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Treatment of arrhythmias in pregnancy can pose a challenge since the potential impact of 
antiarrhythmic drug therapy on the human fetus has not been well studied. The use of beta-
blockers is generally considered safe particularly in the later stages of pregnancy although 
they are associated with fetal bradycardia, neonatal hypoglycemia and intra-uterine growth 
restriction.  Calcium-channel antagonists such as verapamil are also considered safe in the 
second  and  third  trimester  both  for  inhibition  of  pre-term  labor  and  for  treatment  of 
arrhythmias. However, in our patient neither drug was effective in suppressing her VT and 
therefore  catheter  ablation  was  performed.                                 
Catheter  ablation  for  drug-resistant  supraventricular  (but  not  ventricular)  arrhythmias 
complicating pregnancy has been well described in small series and isolated case-reports. In 
the  largest  series  of  nine  patients  ranging  from  12-38  weeks  gestation,  ablation  was 
performed  for  a  variety  of  supraventricular  arrhythmias.[4]  Successful  ablation  without 
complication was achieved in all patients using either minimal or zero fluoroscopy. The latter 
can  be  facilitated  by  the  use  of  electroanatomic  mapping  systems  and/or  intra-cardiac 
echocardiography [4] and is attractive in pregnancy to minimise risk to the fetus. Guidelines 
suggest  that  after  the  first  trimester  there  is  no  evidence  of  an  increased  fetal  risk  of 
congenital  malformations,  intellectual  disability,  growth  restriction,  or  pregnancy  loss  at 
doses  of  radiation  to  the  pregnant  woman  of  <50  mGy.[5]                         
Recent European guidelines propose that catheter ablation of VT should be considered in 
pregnancy  in  the  case  of  drug-refractory  and  poorly  tolerated  tachycardia  (Class  IIb 
recommendation,  level  of evidence  C).[5] To the best  of our knowledge,  this  is  the first 
report describing successful catheter ablation for new-onset right ventricular outflow tract VT 
during  pregnancy.  This  arrhythmia  is  usually  well  tolerated,  is  often  sensitive  to  beta-
blockers or verapamil  and frequently improves  or disappears completely during the post-
partum period.[2] However, our patient was refractory to antiarrhythmic drug therapy and, 
owing  to  increasingly  unstable  episodes,  underwent  successful  definitive  treatment  with 
catheter  ablation  without  complication.                                     
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